ACADIA Pharmaceuticals Inc banner

ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 21.84 USD 0.65% Market Closed
Market Cap: $3.7B

Wall St Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 32.19 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

Lowest Forecast
Price Target
17.17 USD
21% Downside
Average Forecast
Price Target
32.19 USD
47% Upside
Highest Forecast
Price Target
47.25 USD
116% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
SSRM
SSR Mining Inc
72% Upside
IPAR
Inter Parfums Inc
15% Upside
AREC
American Resources Corp
190% Upside
PTCT
PTC Therapeutics Inc
26% Upside

Revenue
Forecast

N/A
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 8 years is 9%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for ACADIA Pharmaceuticals Inc

Operating Income
Forecast

N/A
Past Growth
27% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
27% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 8 years is 27%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for ACADIA Pharmaceuticals Inc

Net Income
Forecast

N/A
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 8 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ACAD's stock price target?
Price Target
32.19 USD

According to Wall Street analysts, the average 1-year price target for ACAD is 32.19 USD with a low forecast of 17.17 USD and a high forecast of 47.25 USD.

What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%

The compound annual growth rate for Revenue over the next 8 years is 9%.

What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%

The compound annual growth rate for Operating Income over the next 8 years is 27%.

What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
7%

The compound annual growth rate for Net Income over the next 8 years is 7%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett